Company

Vectorious Medical Technologies Ltd.

Vectorious Medical Technologies Ltd. develops the V-LAP System, an implanted device for continuous left atrial pressure monitoring in heart failure.

About

Vectorious Medical Technologies Ltd. develops the investigational V-LAP System, a device implanted in the interatrial septum that continuously measures left atrial pressure to support heart failure management. Founded in 2011 by Eyal Orion and Oren Goldstein and based in Tel Aviv-Yafo, Israel, the company raised USD 2.000 mn in Series B funding in July 2018. Edwards Lifesciences Corp acquired the company in 2025.

4Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in